Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-24-000016

Chief Operating Officer acquired 1,531,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kurtoglu Metin · Chief Operating Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2024-01-02 Grant or award : show line 1 in the form +1,531,000 1,531,000 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-01-02 Grant or award : show line 2 in the form Employee Stock Option (right to buy) +1,965,000 1,965,000 D
Loading xslF345X05/wk-form4_1704405809.xml…